← All agents | ← Research tracker
Hyperbaric Oxygen Therapy (HBOT)
Also known as: Hyperbaric Oxygen Therapy (HBOT)
PubChem entry
Evidence Summary
Evidence Level: Moderate
Mechanism: Enrollment: Actual, Enrollment: Estimated, Neurological / Autonomic, Sponsor Type: Other
Safety: Limited specific safety data in these populations. Review full prescribing information and consult specialist. Many agents used off-label or investigational.
Dosing: See linked studies/trials for reported doses and durations; typical protocols vary widely.
Investigational for listed conditions. 5 associated trial(s) and 1 study reference(s) in current data. Review primary sources and consult specialists before use.
Related Conditions
Long COVID (no page yet) · ME/CFS (no page yet)
Clinical Trials
5 trial(s) registered
NCT06452095: Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine Trial - Effect of Hyperbaric Oxygen Therapy for the Treatment of P NA RECRUITING
NCT04842448: Safety and Efficacy of Hyperbaric Oxygen Therapy for Long COVID Syndrome PHASE2 COMPLETED
NCT06267300: Treatment of Post-COVID-19 With Hyperbaric Oxygen Therapy: a Randomized, Controlled Trial PHASE3 UNKNOWN
NCT04905888: Hyperbaric Oxygen for Long COVID-19 Pulmonary Sequela PHASE2 WITHDRAWN
NCT07621068: Hyperbaric Oxygen Therapy for Chronic Fatigue Syndrome (CFS) NA NOT_YET_RECRUITING
Key Studies / References